Researchers led by Professor Steve Watson and Dr. Eleyna Martin from the Institute of Cardiovascular Sciences at the University of Birmingham have delivered a breakthrough for thrombosis researchers, by producing the first ...
Oct 12, 2023
0
12
In some patients, infection with the pandemic virus SARS-CoV-2 can trigger a dangerous immune response in hardened fatty deposits (plaques) lining the heart's largest blood vessels, a new study shows.
Sep 28, 2023
0
44
Trust your gut? Your doctor likely will, too. Probiotics engineered to sense and report signs of bowel inflammation could deliver firsthand knowledge of your system's inner workings—provided they are not killed or dispersed ...
Aug 16, 2023
0
66
Researchers at Masaryk University, Czech Republic, have innovated a technique to track bone development, growth dynamics and healing in a mouse model. In their paper, "Spatiotemporal monitoring of hard tissue development ...
Neurons are the cells that constitute neural circuits and use chemicals and electricity to receive and send messages that allow the body to do everything, including thinking, sensing, moving, and more. Neurons have a long ...
Jul 28, 2023
0
32
Researchers have proposed using emulsion microgels for drug delivery to the bladder. This promises to make the treatment of urinary tract infections more effective and less painful. The microgels contain whey protein capable ...
Jul 27, 2023
0
1
Zinc is one of those micronutrients that many people know they need but are otherwise a little vague on the particulars.
Jul 26, 2023
0
693
Researchers led by Katsunori Tanaka at the RIKEN Cluster for Pioneering Research (CPR) in Japan and Hiromitsu Haba at the RIKEN Nishina Center for Accelerator-Based Science (RNC) have developed a new technique that has the ...
Jun 27, 2023
0
109
When we breathe, the SARS-CoV-2 virus enters the body through the cells of the upper respiratory tract. Sensing an invader, the epithelial cells, which are the first line of defense, mount an immediate and broad "innate" ...
Jun 22, 2023
0
45
Ruxolitinib, a drug that is already approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers and skin conditions, is effective at inhibiting CaMKII, a protein kinase linked to cardiac arrhythmias.
Jun 21, 2023
1
66
